Please log in or create an account to view the Recorded Sessions below.

OAR Webinar Series #3: Buprenorphine Induction Beyond the Basics Micro-induction and how to prevent precipitated withdrawal in the age of synthetic fentanyl analogs   The Poison Control Center’s Opioid Assistance Resource (OAR) organized a 4-part virtual webinar series focusing on prescribing, family and pediatric approaches to opioid use disorder (OUD) care, and the landscape of substance and opioid treatment in Philadelphia. This series is part of the OAR collection with support from the Health Federation of Philadelphia's Substance Use Response Guidance and Education (SURGE) program In a view of the fact that avoiding precipitated withdrawal is a priority for both the patient and the provider when starting buprenorphine for the treatment of opioid use disorder, this program Led by Dr. Joseph D'Orazio, MD aimed to review practices to prevent precipitated withdrawal. As the drug supply has become more potent, approaches to buprenorphine have needed to adapt.  While still relevant to patients who are dependent on opioid pills obtained from a pharmacy, the standard induction that was taught as the primary means of buprenorphine initiation during the first few years of the opioid crisis can cause precipitated withdrawal for patients who are dependent to fentanyl.  Presenter: Dr. Joseph D'Orazio, MD, FAAEM, FACMT Dr. D'Orazio is a medical toxicologist and serves as the Director of the division of emergency, medical toxicology and addiction medicine at Temple University Hospital, as well as a medical toxicology consultant for Children’s Hospital of Philadelphia. Dr. D'Orazio is active in communicating with other experts in the field about drug supply treating withdrawal with other providers across health systems. The Poison Control Center at CHOP’s Opioid Assistance Resource: The Poison Control Center at CHOP provides Philadelphia’s medical community with Opioid Assistance Resource support via our 24/7 phone line: 800-222-1222. OAR is here to help you with managing opioid toxicity and initiating buprenorphine for Opioid Use Disorder. Learn More
OAR Webinar Series #2: Adolescent Opioid Use Disorder The Poison Control Center’s Opioid Assistance Resource (OAR) organized a 4-part virtual webinar series focusing on prescribing, family and pediatric approaches to opioid use disorder (OUD) care, and the landscape of substance and opioid treatment in Philadelphia. This series is part of the OAR collection with support from the Health Federation of Philadelphia's Substance Use Response Guidance and Education (SURGE) program This session explored evidence demonstrating how addiction can be considered a pediatric disease as well as treatment currently provided to adolescent patients with Opioid Use Disorder (OUD). Survey data on substance use and overdose death rates among youth was reviewed along with Medications for Opioid Use Disorder (MOUD) for Adolescents, use of telehealth visits, as well as special developmental, ethical, and legal issues. Presenter: Dr. Krishna White, MD, MPH  Dr. White is an Attending Physician of Adolescent & Addiction Medicine, the Interim Medical Director for Adolescent Medicine Outpatient Clinical Operations, and the Medical Director of Substance Abuse Services for the Craig-Dalsimer Division of Adolescent Medicine at Children’s Hospital of Philadelphia. She is also an Associate Professor of Clinical Pediatrics at the Perelman School of Medicine, University of Pennsylvania. The Poison Control Center at CHOP’s Opioid Assistance Resource: The Poison Control Center at CHOP provides Philadelphia’s medical community with Opioid Assistance Resource support via our 24/7 phone line: 800-222-1222. OAR is here to help you with managing opioid toxicity and initiating buprenorphine for Opioid Use Disorder. Learn More
OAR Webinar Series #1: The Pediatric Impact of the Opioid Epidemic The Poison Control Center’s Opioid Assistance Resource (OAR) organized a 4-part virtual webinar series focusing on prescribing, family and pediatric approaches to opioid use disorder (OUD) care, and the landscape of substance and opioid treatment in Philadelphia. This series is part of the OAR collection with support from the Health Federation of Philadelphia's Substance Use Response Guidance and Education (SURGE) program This session explored the many ways in which opioid epidemic affects pediatric medicine, from toddler exploratory poisonings, to young patients’ parental loss, neonatal abstinence syndrome to adolescent opioid use disorder. In addition, this program looked at child injury epidemiology and focus on child injury prevention. Attendees learned how they can reduce the harm of the opioid epidemic by sharing key public health messages with caretakers of pediatric patients.  Presenter: Dr. Kevin Osterhoudt, MD Dr. Kevin Osterhoudt is an attending physician in the Division of Emergency Medicine, and the medical director of the Poison Control Center, at the Children's Hospital of Philadelphia (CHOP) and is Professor of Pediatrics at the University of Pennsylvania School of Medicine. Dr. Osterhoudt is an Associate Fellow for the Center for Injury Prevention and Research at CHOP and is a member of the Executive Committee of the American Academy of Pediatrics’ Council on Injury, Violence and Poisoning Prevention. The Poison Control Center at CHOP’s Opioid Assistance Resource: The Poison Control Center at CHOP provides Philadelphia’s medical community with Opioid Assistance Resource support via our 24/7 phone line: 800-222-1222. OAR is here to help you with managing opioid toxicity and initiating buprenorphine for Opioid Use Disorder. Learn More